Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients

V. Raj R. (Puducherry, India), T. Anitha (Puducherry, India), R. Pajanivel (Puducherry, India), C. Adithan (Puducherry, India), K. Surendra Menon (Puducherry, India)

Source: International Congress 2018 – New developments in tuberculosis
Session: New developments in tuberculosis
Session type: Oral Presentation
Number: 1955
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Raj R. (Puducherry, India), T. Anitha (Puducherry, India), R. Pajanivel (Puducherry, India), C. Adithan (Puducherry, India), K. Surendra Menon (Puducherry, India). Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients. 1955

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Plasma endocan is over-expressed in AECOPD patients: association with lung function decline and apoptosis
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Relation between level of acute phase proteins and efficiency of treatment in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006

Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time.
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019




Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Study of inflammatory markers in sputum positive patients of pulmonary tuberculosis and its response to anti-tubercular treatment
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Differential microRNA expression in plasma of patients with pulmonary tuberculosis
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015

The change in serum Ca 19-9 levels according to treatment responses in pulmonary nontuberculous mycobacterial disease
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015


Late Breaking Abstract - Hypoxia-induced cellular responses in lung fibroblasts from COPD patients and controls
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Correlation between matrix metalloproteinase-9 serum levels and disease severity in pulmonary tuberculosis patients
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016


Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD.
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019



Decreased miR-150-5p and miR-23a-3p expressions in patients with active Pulmonary Tuberculosis (TB) disease
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019

Late Breaking Abstract - Blood and bronchoalveolar neutrophil signatures associate with COPD severity
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Levels of IL-1β and TNFα production in patients with lung tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002

Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019



Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019


C-reactive protein and pulmonary tuberculosis: What correlation with disease severity
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Alterations in gene expression of RAGE and its sheddases in blood of COPD patients do not relate to decreased plasma (e)sRAGE levels
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014

Late Breaking Abstract - Endobronchial gene-expression clustering in COPD identifies a subgroup with higher level of lymphocytes and accelerated lung function decline
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018